DEFA14A: Masimo Partners with Qualcomm and Google to Develop Next-Generation Smartwatch Reference Platforms

Masimo collaborates with Qualcomm and Google to create reference platforms for Wear OS smartwatches, aiming to streamline OEM development and enhance device performance with advanced biosensing technology.

Summary

• Masimo has partnered with Qualcomm Technologies to develop a next-generation smartwatch reference platform for OEMs building Wear OS by Google smartwatches.
• The platform will combine Masimo's biosensing technologies with Snapdragon wearable platforms.
• The goal is to help OEMs efficiently build and bring high-performing, premium smartwatches to market.
• Masimo is also partnering with Google to develop a new reference platform for Wear OS smartwatches.
• This platform will incorporate Masimo's biosensing technologies and standardize smartwatch devices.
• OEMs will be able to efficiently build and bring high-performing Wear OS smartwatches to market.
• The Masimo reference platform will include key hardware and software components.
• The platform is expected to be compatible with existing Google apps and services created for the Wear OS platform.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the strategic partnerships with major technology players like Qualcomm and Google, which are expected to drive innovation and growth for Masimo in the wearable technology market. The emphasis on clinically proven technology and improved user experiences further contributes to the positive outlook.

Positives

• The partnerships with Qualcomm and Google are expected to accelerate the development and launch of high-performing Wear OS smartwatches.
• The reference platforms will provide OEMs with standardized packages, making it easier to implement Masimo's biosensing technologies.
• Masimo's biosensing technologies are clinically proven and used in leading hospitals worldwide.
• The partnerships will broaden the range of smartwatch choices for consumers.
• The Masimo platform is expected to be compatible with existing Google apps and services.

Risks

• The forward-looking statements are subject to risks and uncertainties, including the repeatability of clinical results and the success of the implementation of Masimo SafetyNet.
• There are uncertainties regarding future actions that may be taken by Politan in furtherance of its nomination of director candidates for election at the 2024 Annual Meeting.
• The potential cost and management distraction attendant to Politans nomination of director nominees at the 2024 Annual Meeting is a risk.

Future Outlook

The partnerships with Qualcomm and Google are expected to drive innovation and growth in the Wear OS smartwatch market, leveraging Masimo's biosensing technologies and expertise.

Management Comments

• Joe Kiani, Founder and CEO of Masimo, said, 'Were thrilled to be able to partner with Qualcomm Technologies...to craft a truly remarkable reference platform.'
• Joe Kiani, Founder and CEO of Masimo, said, 'Were excited to partner with Google to develop a reference platform for Wear OS that leverages our expert engineering capabilities.'
• Bjorn Kilburn, GM of Wear OS at Google, added, 'With Masimo's reference platform, smartwatch makers are able to benefit from state-of-the-art biosensing technology and quickly bring their Wear OS devices to market, at scale.'

Industry Context

These partnerships position Masimo as a key player in the expanding wearable technology market, particularly in the health and wellness sector, by providing critical biosensing technology for smartwatch development.

Comparison to Industry Standards

• Masimo's SET technology is considered a gold standard in pulse oximetry, used in top U.S. hospitals and studied extensively.
• The partnerships with Qualcomm and Google aim to create a competitive advantage for Wear OS smartwatches by incorporating Masimo's clinically proven biosensing capabilities, similar to how hospital monitor manufacturers incorporate Masimo technologies.
• Comparable companies in the biosensing and wearable technology space include Apple, Fitbit (Google), and Garmin, but Masimo differentiates itself with its focus on medical-grade accuracy and hospital-proven technologies.

Stakeholder Impact

• Shareholders may benefit from the potential for increased revenue and market share through the partnerships.
• Employees may have opportunities to work on innovative wearable technology projects.
• Customers can expect to see more high-performing Wear OS smartwatches with accurate health and wellness tracking features.
• Suppliers may see increased demand for components used in smartwatch manufacturing.

Next Steps

• OEMs will adopt the new reference platforms to design and produce Wear OS smartwatches.
• Masimo will continue to design, provide, and test the devices' interiors, including hardware, software, and biosensors.
• Masimo and Google will work together to offer OEMs an incredible Wear OS smartwatch solution.

Key Dates

Keywords

Masimo, Qualcomm, Google, Wear OS, smartwatch, reference platform, biosensing, OEM, technology, health, monitoring